Insider Transactions in Q1 2023 at Viridian Therapeutics, Inc.\De (VRDN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Scott Dunseth Myers Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,500
+2.11%
|
$159,500
$29.15 P/Share
|
|
Mar 09
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
29,971
-100.0%
|
$869,159
$29.07 P/Share
|
|
Feb 06
2023
|
Scott Dunseth Myers Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
|
Feb 02
2023
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-10.4%
|
$1,800,000
$36.8 P/Share
|
|
Jan 23
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,843
-100.0%
|
$239,505
$35.66 P/Share
|
|
Jan 23
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,843
+35.74%
|
$123,174
$18.52 P/Share
|
|
Jan 17
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,853
-100.0%
|
$919,561
$37.21 P/Share
|
|
Jan 17
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,853
+50.0%
|
$571,619
$23.03 P/Share
|
|
Jan 13
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,147
-100.0%
|
$153,439
$37.01 P/Share
|
|
Jan 13
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,147
+50.0%
|
$95,381
$23.03 P/Share
|
|
Jan 10
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
47,377
-100.0%
|
$1,658,195
$35.3 P/Share
|
|
Jan 10
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,377
+50.0%
|
$1,089,671
$23.03 P/Share
|
|
Jan 09
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,623
-100.0%
|
$416,559
$33.04 P/Share
|
|
Jan 09
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,623
+50.0%
|
$290,329
$23.03 P/Share
|